» Auto updated continuously
Display limited to 'Reasanz' in document titles and meta descriptions. Display In Whole Documents or use the calendar above to adjust the date setting.
FDA Advisory Panel Recommends Against Approval Of Novartis Heart Failure Drug... +
(Updated with a statement from Novartis) The FDA'sÂ Cardiovascu
CHMP: No to Serelaxin (Reasanz), Yes to Riociguat (Adempas)... +
The EMA's CHMP made two decisions this week on cardio-related drugs, saying yes to riociguat for the treatment of pulmonary hypertension, but no to serelaxin for the treatment of acute heart failure. International Approvals...